Alerts will be sent to your verified email
Verify Email
SAILIFE
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms. It possesses both (a) discovery / contract research and (b) chemistry, manufacturing, and control / contract development and manufacturing organization capabilities.
Sai Life Sciences major competitors are Divi's Lab, Cohance Lifesciences, Syngene Internation..
Market Cap of Sai Life Sciences is ₹16,898 Crs.
While the median market cap of its peers are ₹38,161 Crs.
Sai Life Sciences seems to be less financially stable compared to its competitors.
Altman Z score of Sai Life Sciences is 9.42 and is ranked 4 out of its 4 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May | Dec | ||||||||||||||||
| Investor Presentation | May | Dec | ||||||||||||||||
| Conference Call | Mar | Dec | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
